Literature DB >> 6096859

Mouse c-mos oncogene activation is prevented by upstream sequences.

T G Wood, M L McGeady, B M Baroudy, D G Blair, G F Vande Woude.   

Abstract

Although the molecularly cloned mouse c-mos oncogene locus can be efficiently activated by insertion of a retroviral long terminal repeat (LTR) 5' to its coding region, only low-frequency transformation occurs with the LTR element inserted 3' to this region. Analysis of several of the latter transformed cell lines suggested that loss of 2 kilobases (kb) of normal mouse DNA sequences preceding c-mos was required for oncogene activation. The determination of the transforming potential of deletion mutants containing only portions of this region followed by analysis of their nucleotide sequences identified a region termed upstream mouse sequence (UMS) as a cis-acting locus that prevents c-mos activation by a 3' LTR. The UMS region is approximately 1 kb in length and is located 0.8-1.8 kb upstream from the first ATG in the open reading frame of c-mos. Insertion of UMS 5' to the v-mos coding region also prevents 3' LTR enhancement of its transforming activity, but this inhibition is position dependent and functions only when inserted between v-mos and its putative promoter. The results presented here suggest that UMS may function to regulate c-mos proto-oncogene expression and may explain the lack of detectable c-mos transcripts in normal mouse cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096859      PMCID: PMC392243          DOI: 10.1073/pnas.81.24.7817

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Sequence at the 3' end of globin mRNA shows homology with immunoglobulin light chain mRNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1974-11-29       Impact factor: 49.962

5.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes.

Authors:  J C Alwine; D J Kemp; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  A virus-induced rhabdomyosarcoma of mice.

Authors:  J B Moloney
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

7.  Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels.

Authors:  M W McDonell; M N Simon; F W Studier
Journal:  J Mol Biol       Date:  1977-02-15       Impact factor: 5.469

8.  Are U4 small nuclear ribonucleoproteins involved in polyadenylation?

Authors:  S M Berget
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

9.  Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus.

Authors:  A E Frankel; P J Fischinger
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

10.  Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus.

Authors:  A E Frankel; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

View more
  22 in total

1.  The COOH-terminal domain of wild-type Cot regulates its stability and kinase specific activity.

Authors:  Maria Luisa Gándara; Pilar López; Raquel Hernando; José G Castaño; Susana Alemany
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells.

Authors:  S S Zinkel; S K Pal; J Szeberényi; G M Cooper
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Transcriptional activation of the CEF-4/9E3 cytokine gene by pp60v-src.

Authors:  M Dehbi; A Mbiguino; M Beauchemin; G Chatelain; P A Bédard
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  mos gene transforming efficiencies correlate with oocyte maturation and cytostatic factor activities.

Authors:  N Yew; M Oskarsson; I Daar; D G Blair; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

5.  c-mos expression in mouse oocytes is controlled by initiator-related sequences immediately downstream of the transcription initiation site.

Authors:  S K Pal; S S Zinkel; A A Kiessling; G M Cooper
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  The repressor sequence upstream of c-mos acts neither as polyadenylation site nor as transcription termination region.

Authors:  F A van der Hoorn; B Neupert
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

7.  The rat albumin promoter is composed of six distinct positive elements within 130 nucleotides.

Authors:  P Herbomel; A Rollier; F Tronche; M O Ott; M Yaniv; M C Weiss
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

8.  Activation of oncogenicity of the c-rel proto-oncogene.

Authors:  B S Sylla; H M Temin
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  Determinants of rat albumin promoter tissue specificity analyzed by an improved transient expression system.

Authors:  J M Heard; P Herbomel; M O Ott; A Mottura-Rollier; M Weiss; M Yaniv
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

10.  Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene.

Authors:  R Ehrlich; J E Maguire; D S Singer
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.